We
report here an accurate surface organometallic chemistry (SOMC)
approach to propane oxidative dehydrogenation (ODH) using a μ2-oxo-bridged, bimetallic [V2O4(acac)2] (1) (acac = acetylacetonate anion) complex as a precursor. The identity and
the nuclearity of the product of grafting and of the subsequent oxidative
treatment have been systematically studied by means of FT-IR, Raman,
solid-state (SS) NMR, UV–vis DRS, EPR and EXAFS spectroscopies.
We show that the grafting of 1 on the silica surface
under a rigorous SOMC protocol and the subsequent oxidative thermal
treatment lead exclusively to well-defined and isolated monovanadate
species. The resulting material has been tested for the oxidative
dehydrogenation of propane in a moderate temperature range (400–525
°C) and compared with that of silica-supported vanadium catalysts
prepared by the standard impregnation technique. The experimental
results show that the catalytic activity in propane ODH is strongly
upgraded by the degree of isolation of the VO
x
species that can be achieved by employing the SOMC protocol.
Polyisobutenes with a high content of terminal olefinic groups can be synthesized by using manganese(II) initiators in homogeneous solution. These easily accessible complexes initiate the polymerization at room temperature and above, and afford highly reactive, gel-free polyisobutenes with high viscosities. Furthermore, the initiators were successfully used for the copolymerization of isobutene with isoprene. The high activities of the Mn(II) initiators seem to be related to their weakly coordinating nitrile ligands, which are easily displaced by substrate molecules. Replacing the nitrile ligands by other more strongly coordinating ligands such as water reduces the initiator activity significantly. The Mn(II) initiators are surprisingly resistant to temperature.
BackgroundProtein aggregation and its pathological effects are the major cause of several neurodegenerative diseases. In Huntington’s disease an elongated stretch of polyglutamines within the protein Huntingtin leads to increased aggregation propensity. This induces cellular defects, culminating in neuronal loss, but the connection between aggregation and toxicity remains to be established.ResultsTo uncover cellular pathways relevant for intoxication we used genome-wide analyses in a yeast model system and identify fourteen genes that, if deleted, result in higher polyglutamine toxicity. Several of these genes, like UGO1, ATP15 and NFU1 encode mitochondrial proteins, implying that a challenged mitochondrial system may become dysfunctional during polyglutamine intoxication. We further employed microarrays to decipher the transcriptional response upon polyglutamine intoxication, which exposes an upregulation of genes involved in sulfur and iron metabolism and mitochondrial Fe-S cluster formation. Indeed, we find that in vivo iron concentrations are misbalanced and observe a reduction in the activity of the prominent Fe-S cluster containing protein aconitase. Like in other yeast strains with impaired mitochondria, non-fermentative growth is impossible after intoxication with the polyglutamine protein. NMR-based metabolic analyses reveal that mitochondrial metabolism is reduced, leading to accumulation of metabolic intermediates in polyglutamine-intoxicated cells.ConclusionThese data show that damages to the mitochondrial system occur in polyglutamine intoxicated yeast cells and suggest an intricate connection between polyglutamine-induced toxicity, mitochondrial functionality and iron homeostasis in this model system.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-1831-7) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.